XORTX Therapeutics Inc V.XRTX

GO Xortx GO !,,you have BILLIONS of GFRs to TREAT in the??

[SpaceLabs]

world.
As people get OLDER, they have a DECLINING GFR and Kidney is the problem.

With Kidney, ALL the Vital Organs are HURTING and WEAKENING at the same time.

Now is the time to RISE and LIST XRX on the NASDAQ !

[KOkidneydisease]

$2 per share w/140mm shares outstanding = $280,000,000. Seems perfectly doable to me. They are putting the peices in place with respected people to go to big money investors  $.50 per share w/140mm shares outstanding = $70,000,000 dirt cheap $1 per share w/140mm shares outstanding = $140,000,000    cheap  $2 per share w/140mm shares outstanding = $280,000,000  still

[SpaceLabs]

I am with you all along, all we need is a major phrma partner and Nasdaq to take this  beyond $15/shr, very doable and it will. Kidney disease kills many millions and what XRX is doing will be a NOVEL DRUG to help millions live longer and healthier. Get the drugs out there , get 1 or 2  partners to develop it and market this. None to very little competition and that is also not what XRX

[SpaceLabs]

Quadrillions need Xortx Medication, get it done sooner. GFR explained below

[SpaceLabs]

XORTX is on Institutional Radar,,,,,,,,,,,NASDAQ LISTING is imminent quote=SpaceLabs]Quadrillions need Xortx Medication, get it done sooner. GFR explained below [/quote]

[KOkidneydisease]

Hey Lab. Sure appears to be things happening. I picked some more up between $.145 and $.165 and my TFSA is looking better for it! A gift. Love tax free gains!

[SpaceLabs]

I am choking my friend, having dumped $25k in last PP, not happy dude. I am waiting to hear more solid news from the CEO/BOD. This is too cheap here, should be trading above atleast 50cents. Talk Nasdaq and you see what happens and get Institutions to invest if Allen/XRX has anything